☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Acute Graft-Versus-Host Disease
BMS' Orencia (abatacept) Receive the FDA's Breakthrough Therapy Designation to Prevent Acute Graft-Versus-Host Disease After Stem...
December 4, 2019
Mallinckrodt Reports Results of Therakos Photopheresis Therapy in P-III study for Steroid-Refractory Acute Graft-Versus-Host Disea...
February 22, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.